Introduction Changchun Reinovax Biologics Co., Ltd., an integral subsidiary of Shanghai Reinovax Biologics Co., Ltd., specializes in the cutting-edge research, development, and production of bio-products. With its primary focus on addressing vital healthcare needs, the company endeavors to develop a pneumonia conjugate vaccine customized for the Chinese market. In addition to vaccines, Reinovax Biologics explores a multitude of research avenues including genetic engineering, fermentation, purification, immunity, and quality analysis. And it actively collaborates on scientific research projects with national and international counterparts, universities, and research institutions, utilizing its robust technological capabilities and substantial financial resources. |






